Skip to main content

When it comes to finding a cure for neurodegenerative diseases, our team won’t take no for an answer. Progress is made possible thanks to the passion and drive of every Amylyx team member, and we promise to strive to always be true partners to the people and communities affected by these diseases. 

Executive team

Headshot of Debra Canner READ BIO

Debra Canner

Global Head of Human Resources & CHRO

READ BIO
Josh Cohen READ BIO

Josh Cohen

Co-CEO & Co-Founder

READ BIO
Headshot of James M. Frates READ BIO

James M. Frates

Chief Financial Officer

READ BIO
Headshot of Tom Holmes READ BIO

Tom Holmes

Global Head of Supply Chain

READ BIO
Headshot of Justin Klee READ BIO

Justin Klee

Co-CEO & Co-Founder

READ BIO
Gina Mazzariello READ BIO

Gina M. Mazzariello

Chief Legal Officer & General Counsel

READ BIO
Headshot of Margaret Olinger READ BIO

Margaret Olinger

Global Head of Commercial & CCO

READ BIO
Headshot of Patrick Yeramian READ BIO

Patrick Yeramian, MD, MBA

Global Head of Clinical R&D & CMO

READ BIO

Key advisors

Headshot of Rudolph Tanzi READ BIO

Rudolph Tanzi, PhD

Founding Chair of the Amylyx SAB

READ BIO

Be the change

Group photo of Amylyx team standing on stairs together outdoors wearing face masks

Be the change

We’ve made some great strides toward making a difference in patients’ lives — and we’re just getting started. If you’d like to join us in our mission, learn more about our culture and current open positions below.